Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

The effects of levetiracetam on alcohol consumption in alcohol-dependent subjects: an open label study.

Sarid-Segal O, Piechniczek-Buczek J, Knapp C, Afshar M, Devine E, Sickles L, Uwodukunda E, Richambault C, Koplow J, Ciraulo D.

Am J Drug Alcohol Abuse. 2008;34(4):441-7. doi: 10.1080/00952990802082180.

PMID:
18584574
[PubMed - indexed for MEDLINE]
2.

Efficacy and safety of levetiracetam for outpatient alcohol detoxification.

Müller CA, Schäfer M, Schneider S, Heimann HM, Hinzpeter A, Volkmar K, Förg A, Heinz A, Hein J.

Pharmacopsychiatry. 2010 Jul;43(5):184-9. doi: 10.1055/s-0030-1249098. Epub 2010 May 25.

PMID:
20503149
[PubMed - indexed for MEDLINE]
3.

The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers.

Mitchell JM, Grossman LE, Coker AR, Messing RO.

J Clin Psychopharmacol. 2012 Apr;32(2):269-72. doi: 10.1097/JCP.0b013e318248ba69.

PMID:
22367657
[PubMed - indexed for MEDLINE]
4.

A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.

Fertig JB, Ryan ML, Falk DE, Litten RZ, Mattson ME, Ransom J, Rickman WJ, Scott C, Ciraulo D, Green AI, Tiouririne NA, Johnson B, Pettinati H, Strain EC, Devine E, Brunette MF, Kampman K, A Tompkins D, Stout R; NCIG 002 Study Group.

Alcohol Clin Exp Res. 2012 Aug;36(8):1421-30. doi: 10.1111/j.1530-0277.2011.01716.x. Epub 2012 Feb 10.

PMID:
22324516
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Levetiracetam in the treatment of alcohol dependence: toward the end of the story?

Le Strat Y.

Alcohol Clin Exp Res. 2012 Aug;36(8):1309-10. doi: 10.1111/j.1530-0277.2012.01891.x. Epub 2012 Jul 23.

PMID:
22823576
[PubMed - indexed for MEDLINE]
6.

An open-label pilot study of levetiracetam for essential tremor.

Ondo WG, Jimenez JE, Vuong KD, Jankovic J.

Clin Neuropharmacol. 2004 Nov-Dec;27(6):274-7.

PMID:
15613931
[PubMed - indexed for MEDLINE]
7.

Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with levetiracetam: a preliminary study.

Zalewska-Kaszubska J, Bajer B, Czarnecka E, Dyr W, Gorska D.

Physiol Behav. 2011 Mar 28;102(5):538-41. doi: 10.1016/j.physbeh.2010.12.021. Epub 2010 Dec 25.

PMID:
21187108
[PubMed - indexed for MEDLINE]
8.

Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain.

Sills GJ, Leach JP, Fraser CM, Forrest G, Patsalos PN, Brodie MJ.

Eur J Pharmacol. 1997 Apr 23;325(1):35-40.

PMID:
9151936
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial.

Richter C, Effenberger S, Bschor T, Bonnet U, Haasen C, Preuss UW, Heinz A, Förg A, Volkmar K, Glauner T, Schaefer M.

J Clin Psychopharmacol. 2012 Aug;32(4):558-62. doi: 10.1097/JCP.0b013e31825e213e.

PMID:
22722516
[PubMed - indexed for MEDLINE]
10.

Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study.

Striano P, Coppola A, Vacca G, Zara F, Brescia Morra V, Orefice G, Striano S.

J Neurol. 2006 Jun;253(6):762-6. Epub 2006 May 12.

PMID:
16683063
[PubMed - indexed for MEDLINE]
11.

Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.

Specchio N, Boero G, Michelucci R, Gambardella A, Giallonardo AT, Fattouch J, Di Bonaventura C, de Palo A, Ladogana M, Lamberti P, Vigevano F, La Neve A, Specchio LM.

Epilepsia. 2008 Apr;49(4):663-9. doi: 10.1111/j.1528-1167.2007.01523.x. Epub 2008 Feb 5.

PMID:
18266754
[PubMed - indexed for MEDLINE]
12.

Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review.

Mariani JJ, Levin FR.

Am J Drug Alcohol Abuse. 2008;34(6):683-91. doi: 10.1080/00952990802308213.

PMID:
18850500
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects.

Young W, Shaw J, Bloom M, Gebeline-Myers C.

Headache. 2008 Nov-Dec;48(10):1490-8. doi: 10.1111/j.1526-4610.2008.01292.x.

PMID:
19076647
[PubMed - indexed for MEDLINE]
14.

Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.

Zesiewicz TA, Sullivan KL, Hauser RA, Sanchez-Ramos J.

Mov Disord. 2006 Nov;21(11):1998-2001.

PMID:
16941461
[PubMed - indexed for MEDLINE]
15.

Levetiracetam in tardive dyskinesia.

Meco G, Fabrizio E, Epifanio A, Morgante F, Valente M, Vanacore N, Di Rosa AE, Morgante L.

Clin Neuropharmacol. 2006 Sep-Oct;29(5):265-8.

PMID:
16960471
[PubMed - indexed for MEDLINE]
16.

Pharmaco-EEG-based assessment of interaction between ethanol and levetiracetam.

Pietrzak B, Czarnecka E.

Alcohol. 2008 Mar;42(2):115-22. doi: 10.1016/j.alcohol.2007.12.003.

PMID:
18358990
[PubMed - indexed for MEDLINE]
17.

Levetiracetam for the treatment of alcohol withdrawal syndrome: an open-label pilot trial.

Krebs M, Leopold K, Richter C, Kienast T, Hinzpeter A, Heinz A, Schaefer M.

J Clin Psychopharmacol. 2006 Jun;26(3):347-9. No abstract available.

PMID:
16702910
[PubMed - indexed for MEDLINE]
18.

Levetiracetam prophylaxis in pediatric migraine--an open-label study.

Pakalnis A, Kring D, Meier L.

Headache. 2007 Mar;47(3):427-30.

PMID:
17371359
[PubMed - indexed for MEDLINE]
19.

Levetiracetam in three cases of progressive myoclonus epilepsy.

Papacostas S, Kkolou E, Papathanasiou E.

Pharm World Sci. 2007 Jun;29(3):164-6. Epub 2007 Jan 23.

PMID:
17242859
[PubMed - indexed for MEDLINE]
20.

An open trial of levetiracetam for segmental and generalized dystonia.

Hering S, Wenning GK, Seppi K, Poewe W, Mueller J.

Mov Disord. 2007 Aug 15;22(11):1649-51.

PMID:
17557353
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk